image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC1156954_F3_2324.jpg | What is the principal component of this image? | Ultrastructural characteristics of a Coronavirus-Infected cell in BAL fluid from a SARS patient at 60 days, with several intracellular particles. The virions are indicated by the arrowheads in Panel A. Panel B shows the area indicated by the asterisk in Panel A at higher magnification. The bar in Panel A (500 nm) and P... |
PMC1156956_F2_2330.jpg | What is being portrayed in this visual content? | Expression of SPHK1 in PCLS from different mouse strains studied via confocal laser scanning microscopy. Representative confocal laser scanning micrographs of double labeling immunohistochemistry demonstrates the restriction of SPHK1-immunoreactivity to smooth muscle cells, identified by immunoreactivity for the marker... |
PMC1156956_F2_2325.jpg | What is shown in this image? | Expression of SPHK1 in PCLS from different mouse strains studied via confocal laser scanning microscopy. Representative confocal laser scanning micrographs of double labeling immunohistochemistry demonstrates the restriction of SPHK1-immunoreactivity to smooth muscle cells, identified by immunoreactivity for the marker... |
PMC1156956_F2_2332.jpg | What is the main focus of this visual representation? | Expression of SPHK1 in PCLS from different mouse strains studied via confocal laser scanning microscopy. Representative confocal laser scanning micrographs of double labeling immunohistochemistry demonstrates the restriction of SPHK1-immunoreactivity to smooth muscle cells, identified by immunoreactivity for the marker... |
PMC1156956_F2_2334.jpg | Can you identify the primary element in this image? | Expression of SPHK1 in PCLS from different mouse strains studied via confocal laser scanning microscopy. Representative confocal laser scanning micrographs of double labeling immunohistochemistry demonstrates the restriction of SPHK1-immunoreactivity to smooth muscle cells, identified by immunoreactivity for the marker... |
PMC1156956_F2_2329.jpg | What object or scene is depicted here? | Expression of SPHK1 in PCLS from different mouse strains studied via confocal laser scanning microscopy. Representative confocal laser scanning micrographs of double labeling immunohistochemistry demonstrates the restriction of SPHK1-immunoreactivity to smooth muscle cells, identified by immunoreactivity for the marker... |
PMC1156956_F2_2331.jpg | What is the core subject represented in this visual? | Expression of SPHK1 in PCLS from different mouse strains studied via confocal laser scanning microscopy. Representative confocal laser scanning micrographs of double labeling immunohistochemistry demonstrates the restriction of SPHK1-immunoreactivity to smooth muscle cells, identified by immunoreactivity for the marker... |
PMC1156956_F2_2336.jpg | What is the focal point of this photograph? | Expression of SPHK1 in PCLS from different mouse strains studied via confocal laser scanning microscopy. Representative confocal laser scanning micrographs of double labeling immunohistochemistry demonstrates the restriction of SPHK1-immunoreactivity to smooth muscle cells, identified by immunoreactivity for the marker... |
PMC1156956_F2_2328.jpg | What is shown in this image? | Expression of SPHK1 in PCLS from different mouse strains studied via confocal laser scanning microscopy. Representative confocal laser scanning micrographs of double labeling immunohistochemistry demonstrates the restriction of SPHK1-immunoreactivity to smooth muscle cells, identified by immunoreactivity for the marker... |
PMC1156956_F2_2326.jpg | What is the dominant medical problem in this image? | Expression of SPHK1 in PCLS from different mouse strains studied via confocal laser scanning microscopy. Representative confocal laser scanning micrographs of double labeling immunohistochemistry demonstrates the restriction of SPHK1-immunoreactivity to smooth muscle cells, identified by immunoreactivity for the marker... |
PMC1156956_F2_2327.jpg | What is the central feature of this picture? | Expression of SPHK1 in PCLS from different mouse strains studied via confocal laser scanning microscopy. Representative confocal laser scanning micrographs of double labeling immunohistochemistry demonstrates the restriction of SPHK1-immunoreactivity to smooth muscle cells, identified by immunoreactivity for the marker... |
PMC1159039_F2_2348.jpg | What is the principal component of this image? | Simultaneous capture of GFP and CFP. Stable cell lines expressing either GFP or CFP were co-cultured (left panels) or a stable cell line expressing CFP and GFP-CAAX (membrane targeted – middle panels) or a cell line expressing CFP transiently transfected with GFP-ZYXIN (right panels) were analyzed. Top panels show the ... |
PMC1159039_F2_2354.jpg | Can you identify the primary element in this image? | Simultaneous capture of GFP and CFP. Stable cell lines expressing either GFP or CFP were co-cultured (left panels) or a stable cell line expressing CFP and GFP-CAAX (membrane targeted – middle panels) or a cell line expressing CFP transiently transfected with GFP-ZYXIN (right panels) were analyzed. Top panels show the ... |
PMC1159039_F2_2352.jpg | What is the principal component of this image? | Simultaneous capture of GFP and CFP. Stable cell lines expressing either GFP or CFP were co-cultured (left panels) or a stable cell line expressing CFP and GFP-CAAX (membrane targeted – middle panels) or a cell line expressing CFP transiently transfected with GFP-ZYXIN (right panels) were analyzed. Top panels show the ... |
PMC1159039_F2_2350.jpg | What is the principal component of this image? | Simultaneous capture of GFP and CFP. Stable cell lines expressing either GFP or CFP were co-cultured (left panels) or a stable cell line expressing CFP and GFP-CAAX (membrane targeted – middle panels) or a cell line expressing CFP transiently transfected with GFP-ZYXIN (right panels) were analyzed. Top panels show the ... |
PMC1159039_F2_2356.jpg | What is the focal point of this photograph? | Simultaneous capture of GFP and CFP. Stable cell lines expressing either GFP or CFP were co-cultured (left panels) or a stable cell line expressing CFP and GFP-CAAX (membrane targeted – middle panels) or a cell line expressing CFP transiently transfected with GFP-ZYXIN (right panels) were analyzed. Top panels show the ... |
PMC1159039_F3_2339.jpg | What stands out most in this visual? | Simultaneous capture of GFP, CFP and collagen second harmonic fluorescence in a living tissue. The panels on the left-hand side show images of an experimentally generated mammary tumour creating by injecting a mixture of cells either expressing GFP or CFP. The panels on the right-hand side show images of an experimenta... |
PMC1159039_F3_2341.jpg | What is the core subject represented in this visual? | Simultaneous capture of GFP, CFP and collagen second harmonic fluorescence in a living tissue. The panels on the left-hand side show images of an experimentally generated mammary tumour creating by injecting a mixture of cells either expressing GFP or CFP. The panels on the right-hand side show images of an experimenta... |
PMC1159039_F3_2343.jpg | What stands out most in this visual? | Simultaneous capture of GFP, CFP and collagen second harmonic fluorescence in a living tissue. The panels on the left-hand side show images of an experimentally generated mammary tumour creating by injecting a mixture of cells either expressing GFP or CFP. The panels on the right-hand side show images of an experimenta... |
PMC1159039_F3_2342.jpg | What key item or scene is captured in this photo? | Simultaneous capture of GFP, CFP and collagen second harmonic fluorescence in a living tissue. The panels on the left-hand side show images of an experimentally generated mammary tumour creating by injecting a mixture of cells either expressing GFP or CFP. The panels on the right-hand side show images of an experimenta... |
PMC1159039_F3_2344.jpg | What is the dominant medical problem in this image? | Simultaneous capture of GFP, CFP and collagen second harmonic fluorescence in a living tissue. The panels on the left-hand side show images of an experimentally generated mammary tumour creating by injecting a mixture of cells either expressing GFP or CFP. The panels on the right-hand side show images of an experimenta... |
PMC1159039_F4_2358.jpg | What key item or scene is captured in this photo? | Differences in motility and invasion can be determined by imaging cells with different metastatic potential in the same tumor. A) The panels show a time series of images of an experimentally generated mammary tumour with cells either expressing GFP (low metastatic in green) or CFP (high metastatic in white) with collag... |
PMC1159039_F4_2363.jpg | What is the dominant medical problem in this image? | Differences in motility and invasion can be determined by imaging cells with different metastatic potential in the same tumor. A) The panels show a time series of images of an experimentally generated mammary tumour with cells either expressing GFP (low metastatic in green) or CFP (high metastatic in white) with collag... |
PMC1159039_F4_2364.jpg | What can you see in this picture? | Differences in motility and invasion can be determined by imaging cells with different metastatic potential in the same tumor. A) The panels show a time series of images of an experimentally generated mammary tumour with cells either expressing GFP (low metastatic in green) or CFP (high metastatic in white) with collag... |
PMC1159039_F4_2362.jpg | What is the focal point of this photograph? | Differences in motility and invasion can be determined by imaging cells with different metastatic potential in the same tumor. A) The panels show a time series of images of an experimentally generated mammary tumour with cells either expressing GFP (low metastatic in green) or CFP (high metastatic in white) with collag... |
PMC1159039_F4_2361.jpg | What is the central feature of this picture? | Differences in motility and invasion can be determined by imaging cells with different metastatic potential in the same tumor. A) The panels show a time series of images of an experimentally generated mammary tumour with cells either expressing GFP (low metastatic in green) or CFP (high metastatic in white) with collag... |
PMC1159039_F4_2366.jpg | What is shown in this image? | Differences in motility and invasion can be determined by imaging cells with different metastatic potential in the same tumor. A) The panels show a time series of images of an experimentally generated mammary tumour with cells either expressing GFP (low metastatic in green) or CFP (high metastatic in white) with collag... |
PMC1159039_F4_2365.jpg | What is the central feature of this picture? | Differences in motility and invasion can be determined by imaging cells with different metastatic potential in the same tumor. A) The panels show a time series of images of an experimentally generated mammary tumour with cells either expressing GFP (low metastatic in green) or CFP (high metastatic in white) with collag... |
PMC1164403_F1_2375.jpg | What is the core subject represented in this visual? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in normal glandular tissues. Mucosa of the corpus of stomach (a, b; magnification × 10) and (c, d; magnification × 45). Colonic mucosa (e, f; magnification × 25), (g; magnification × 60) and (h; magnification × 50). Pro... |
PMC1164403_F1_2367.jpg | What's the most prominent thing you notice in this picture? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in normal glandular tissues. Mucosa of the corpus of stomach (a, b; magnification × 10) and (c, d; magnification × 45). Colonic mucosa (e, f; magnification × 25), (g; magnification × 60) and (h; magnification × 50). Pro... |
PMC1164403_F1_2372.jpg | What is being portrayed in this visual content? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in normal glandular tissues. Mucosa of the corpus of stomach (a, b; magnification × 10) and (c, d; magnification × 45). Colonic mucosa (e, f; magnification × 25), (g; magnification × 60) and (h; magnification × 50). Pro... |
PMC1164403_F1_2374.jpg | What is the main focus of this visual representation? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in normal glandular tissues. Mucosa of the corpus of stomach (a, b; magnification × 10) and (c, d; magnification × 45). Colonic mucosa (e, f; magnification × 25), (g; magnification × 60) and (h; magnification × 50). Pro... |
PMC1164403_F1_2368.jpg | Describe the main subject of this image. | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in normal glandular tissues. Mucosa of the corpus of stomach (a, b; magnification × 10) and (c, d; magnification × 45). Colonic mucosa (e, f; magnification × 25), (g; magnification × 60) and (h; magnification × 50). Pro... |
PMC1164403_F1_2373.jpg | What stands out most in this visual? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in normal glandular tissues. Mucosa of the corpus of stomach (a, b; magnification × 10) and (c, d; magnification × 45). Colonic mucosa (e, f; magnification × 25), (g; magnification × 60) and (h; magnification × 50). Pro... |
PMC1164403_F1_2371.jpg | What is the central feature of this picture? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in normal glandular tissues. Mucosa of the corpus of stomach (a, b; magnification × 10) and (c, d; magnification × 45). Colonic mucosa (e, f; magnification × 25), (g; magnification × 60) and (h; magnification × 50). Pro... |
PMC1164403_F2_2382.jpg | What does this image primarily show? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in various adenocarcinomas. Signet ring cell gastric carcinoma (a, b; magnification × 80). Colorectal adenocarcinoma (c, d; magnification × 60). Lymph node metastasis (e, f; magnification × 50). Prostatic adenocarcinoma... |
PMC1164403_F2_2386.jpg | What does this image primarily show? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in various adenocarcinomas. Signet ring cell gastric carcinoma (a, b; magnification × 80). Colorectal adenocarcinoma (c, d; magnification × 60). Lymph node metastasis (e, f; magnification × 50). Prostatic adenocarcinoma... |
PMC1164403_F2_2379.jpg | What's the most prominent thing you notice in this picture? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in various adenocarcinomas. Signet ring cell gastric carcinoma (a, b; magnification × 80). Colorectal adenocarcinoma (c, d; magnification × 60). Lymph node metastasis (e, f; magnification × 50). Prostatic adenocarcinoma... |
PMC1164403_F2_2385.jpg | What can you see in this picture? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in various adenocarcinomas. Signet ring cell gastric carcinoma (a, b; magnification × 80). Colorectal adenocarcinoma (c, d; magnification × 60). Lymph node metastasis (e, f; magnification × 50). Prostatic adenocarcinoma... |
PMC1164403_F2_2380.jpg | What does this image primarily show? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in various adenocarcinomas. Signet ring cell gastric carcinoma (a, b; magnification × 80). Colorectal adenocarcinoma (c, d; magnification × 60). Lymph node metastasis (e, f; magnification × 50). Prostatic adenocarcinoma... |
PMC1164403_F2_2381.jpg | What is the principal component of this image? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in various adenocarcinomas. Signet ring cell gastric carcinoma (a, b; magnification × 80). Colorectal adenocarcinoma (c, d; magnification × 60). Lymph node metastasis (e, f; magnification × 50). Prostatic adenocarcinoma... |
PMC1164403_F2_2377.jpg | What stands out most in this visual? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in various adenocarcinomas. Signet ring cell gastric carcinoma (a, b; magnification × 80). Colorectal adenocarcinoma (c, d; magnification × 60). Lymph node metastasis (e, f; magnification × 50). Prostatic adenocarcinoma... |
PMC1164403_F2_2384.jpg | What is the dominant medical problem in this image? | Examples of the different immunostaining patterns obtained using the antibody clones 22-1-1 and Ab-1 in various adenocarcinomas. Signet ring cell gastric carcinoma (a, b; magnification × 80). Colorectal adenocarcinoma (c, d; magnification × 60). Lymph node metastasis (e, f; magnification × 50). Prostatic adenocarcinoma... |
PMC1164415_F1_2387.jpg | What stands out most in this visual? | Type I Gaucher disease with exophthalmos and pulmonary arteriovenous malformation. (A) MRI of the head shows increases in retrobulbar space and hypertrophy of extra-ocular muscles. (B) Chest X ray reveals prominent pulmonary conus and increased infiltration over right lower lung field. (C) High-resolution computed tomo... |
PMC1164415_F1_2389.jpg | What is the core subject represented in this visual? | Type I Gaucher disease with exophthalmos and pulmonary arteriovenous malformation. (A) MRI of the head shows increases in retrobulbar space and hypertrophy of extra-ocular muscles. (B) Chest X ray reveals prominent pulmonary conus and increased infiltration over right lower lung field. (C) High-resolution computed tomo... |
PMC1164418_F2_2395.jpg | What object or scene is depicted here? | The same patient as in Fig. 1: The Artifact due to dental mass (Fig. 1) is not visible in the CT-corrected images with segmentation of transmission data. |
PMC1164418_F2_2396.jpg | What stands out most in this visual? | The same patient as in Fig. 1: The Artifact due to dental mass (Fig. 1) is not visible in the CT-corrected images with segmentation of transmission data. |
PMC1164418_F4_2391.jpg | What is the principal component of this image? | The same patient as in Fig. 3: There is no pathological uptake in the periprosthetic area of the right hip in the CT-corrected images with segmentation of transmission data. |
PMC1164418_F4_2392.jpg | What is being portrayed in this visual content? | The same patient as in Fig. 3: There is no pathological uptake in the periprosthetic area of the right hip in the CT-corrected images with segmentation of transmission data. |
PMC1164436_F1_2398.jpg | What is the main focus of this visual representation? | Chest X-ray and Computerized tomographic scan showing multiple metastatic nodules in the lung |
PMC1164436_F1_2397.jpg | What object or scene is depicted here? | Chest X-ray and Computerized tomographic scan showing multiple metastatic nodules in the lung |
PMC1166561_F1_2409.jpg | What is the principal component of this image? | OIS response to low vs. high amplitude stimulation. OIS images taken from three subjects (A, B, C). All images are anatomically oriented as shown in the top left image. Images were obtained by averaging across 10 experimental trials and then summing frames taken from the time of stimulus onset to 5 seconds after stimul... |
PMC1166561_F1_2401.jpg | What is shown in this image? | OIS response to low vs. high amplitude stimulation. OIS images taken from three subjects (A, B, C). All images are anatomically oriented as shown in the top left image. Images were obtained by averaging across 10 experimental trials and then summing frames taken from the time of stimulus onset to 5 seconds after stimul... |
PMC1166561_F1_2407.jpg | What object or scene is depicted here? | OIS response to low vs. high amplitude stimulation. OIS images taken from three subjects (A, B, C). All images are anatomically oriented as shown in the top left image. Images were obtained by averaging across 10 experimental trials and then summing frames taken from the time of stimulus onset to 5 seconds after stimul... |
PMC1166561_F1_2406.jpg | Can you identify the primary element in this image? | OIS response to low vs. high amplitude stimulation. OIS images taken from three subjects (A, B, C). All images are anatomically oriented as shown in the top left image. Images were obtained by averaging across 10 experimental trials and then summing frames taken from the time of stimulus onset to 5 seconds after stimul... |
PMC1166561_F1_2405.jpg | What object or scene is depicted here? | OIS response to low vs. high amplitude stimulation. OIS images taken from three subjects (A, B, C). All images are anatomically oriented as shown in the top left image. Images were obtained by averaging across 10 experimental trials and then summing frames taken from the time of stimulus onset to 5 seconds after stimul... |
PMC1166561_F1_2400.jpg | What is the core subject represented in this visual? | OIS response to low vs. high amplitude stimulation. OIS images taken from three subjects (A, B, C). All images are anatomically oriented as shown in the top left image. Images were obtained by averaging across 10 experimental trials and then summing frames taken from the time of stimulus onset to 5 seconds after stimul... |
PMC1166561_F1_2399.jpg | What is the principal component of this image? | OIS response to low vs. high amplitude stimulation. OIS images taken from three subjects (A, B, C). All images are anatomically oriented as shown in the top left image. Images were obtained by averaging across 10 experimental trials and then summing frames taken from the time of stimulus onset to 5 seconds after stimul... |
PMC1166561_F1_2404.jpg | What stands out most in this visual? | OIS response to low vs. high amplitude stimulation. OIS images taken from three subjects (A, B, C). All images are anatomically oriented as shown in the top left image. Images were obtained by averaging across 10 experimental trials and then summing frames taken from the time of stimulus onset to 5 seconds after stimul... |
PMC1166574_F3_2420.jpg | What stands out most in this visual? | Immunohistochemistry of TGF-β1 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F3_2418.jpg | What is the main focus of this visual representation? | Immunohistochemistry of TGF-β1 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F3_2416.jpg | What object or scene is depicted here? | Immunohistochemistry of TGF-β1 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F3_2419.jpg | What is the core subject represented in this visual? | Immunohistochemistry of TGF-β1 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F3_2421.jpg | What is the focal point of this photograph? | Immunohistochemistry of TGF-β1 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F4_2415.jpg | What key item or scene is captured in this photo? | Immunohistochemistry of TGF-β2 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F4_2411.jpg | What is the focal point of this photograph? | Immunohistochemistry of TGF-β2 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F4_2410.jpg | What is the focal point of this photograph? | Immunohistochemistry of TGF-β2 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F4_2412.jpg | What stands out most in this visual? | Immunohistochemistry of TGF-β2 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F4_2413.jpg | What is the dominant medical problem in this image? | Immunohistochemistry of TGF-β2 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per day of pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F5_2425.jpg | What is being portrayed in this visual content? | Immunohistochemistry of TGF-β3 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per of day pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F5_2422.jpg | What can you see in this picture? | Immunohistochemistry of TGF-β3 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per of day pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F5_2426.jpg | What is the core subject represented in this visual? | Immunohistochemistry of TGF-β3 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per of day pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166574_F5_2423.jpg | What is shown in this image? | Immunohistochemistry of TGF-β3 in rat endometrium during pregnancy. IHC shown are from one representative experiment and were repeated 6 times using 6 different uterine sections from 6 different rats per of day pregnancy. Representative days of pregnancy are presented (A: day 4; B: day 5.5; C: day 6.5; D: day 10; E: da... |
PMC1166581_F1_2428.jpg | Describe the main subject of this image. | Computed tomography scanner showing a large left-pararenal mass (Hyalin-vascular type of Castleman's disease). Note the presence of microcalcification (white spot) within the mass. |
PMC1173139_F1_2431.jpg | What is the main focus of this visual representation? | Posterior-anterior view of a chest X-ray film demonstrated a huge mass shadow in the left upper lung field. |
PMC1173139_F3_2432.jpg | What stands out most in this visual? | Computerised tomographic scan before and after treatment. A) Abdominal CT showed multiple lymph node swelling, suggesting the presence of metastases (arrowhead). B) Abdominal CT showed the lymph nodes metastases to have completely disappeared. |
PMC1173139_F3_2433.jpg | What is the dominant medical problem in this image? | Computerised tomographic scan before and after treatment. A) Abdominal CT showed multiple lymph node swelling, suggesting the presence of metastases (arrowhead). B) Abdominal CT showed the lymph nodes metastases to have completely disappeared. |
PMC1174869_F3_2434.jpg | Can you identify the primary element in this image? | X-ray of abdomen 2 years prior showing outline of plastic soda bottle in sigmoid colon (arrows). |
PMC1174941_F3_2440.jpg | What object or scene is depicted here? | Peptidyl arginine deiminase 4 (PAD4) is present in the arthritic joint. PAD4 was detected in infiltrating cells (a), localised to the cytoplasm of mononuclear cells (c,e). Unimmunised animals were negative for PAD4 staining (f). Immunohistochemical stainings were performed with a rabbit anti-PAD4 antibody. Control stai... |
PMC1174941_F3_2435.jpg | What can you see in this picture? | Peptidyl arginine deiminase 4 (PAD4) is present in the arthritic joint. PAD4 was detected in infiltrating cells (a), localised to the cytoplasm of mononuclear cells (c,e). Unimmunised animals were negative for PAD4 staining (f). Immunohistochemical stainings were performed with a rabbit anti-PAD4 antibody. Control stai... |
PMC1174941_F3_2439.jpg | What can you see in this picture? | Peptidyl arginine deiminase 4 (PAD4) is present in the arthritic joint. PAD4 was detected in infiltrating cells (a), localised to the cytoplasm of mononuclear cells (c,e). Unimmunised animals were negative for PAD4 staining (f). Immunohistochemical stainings were performed with a rabbit anti-PAD4 antibody. Control stai... |
PMC1174941_F3_2437.jpg | What object or scene is depicted here? | Peptidyl arginine deiminase 4 (PAD4) is present in the arthritic joint. PAD4 was detected in infiltrating cells (a), localised to the cytoplasm of mononuclear cells (c,e). Unimmunised animals were negative for PAD4 staining (f). Immunohistochemical stainings were performed with a rabbit anti-PAD4 antibody. Control stai... |
PMC1174952_F1_2443.jpg | What is the principal component of this image? | The three-dimensional poly(lactic-glycolic acid) (3D-PLGA) scaffold. The micropore side (cell seeding side) (a) and a cross section (b) of the scaffold. Schematic illustration of cell seeding (left) and scanning electron photomicrograph of cross section of cells seeded in the 3D-PLGA scaffold (right) (c). The cells lie... |
PMC1174952_F1_2441.jpg | What key item or scene is captured in this photo? | The three-dimensional poly(lactic-glycolic acid) (3D-PLGA) scaffold. The micropore side (cell seeding side) (a) and a cross section (b) of the scaffold. Schematic illustration of cell seeding (left) and scanning electron photomicrograph of cross section of cells seeded in the 3D-PLGA scaffold (right) (c). The cells lie... |
PMC1175028_F1_2444.jpg | What is the principal component of this image? | Dynamic gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)-enhanced MRI of the wrist in a patient with psoriatic arthritis. Sequence (a) shows the precontrast image; sequences (b–d) show images acquired after 36, 90, and 180 s, respectively. The region of interest on which the enhancement curve has been calculate... |
PMC1175028_F1_2446.jpg | What stands out most in this visual? | Dynamic gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)-enhanced MRI of the wrist in a patient with psoriatic arthritis. Sequence (a) shows the precontrast image; sequences (b–d) show images acquired after 36, 90, and 180 s, respectively. The region of interest on which the enhancement curve has been calculate... |
PMC1175028_F1_2445.jpg | What is the dominant medical problem in this image? | Dynamic gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)-enhanced MRI of the wrist in a patient with psoriatic arthritis. Sequence (a) shows the precontrast image; sequences (b–d) show images acquired after 36, 90, and 180 s, respectively. The region of interest on which the enhancement curve has been calculate... |
PMC1175028_F1_2447.jpg | What can you see in this picture? | Dynamic gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)-enhanced MRI of the wrist in a patient with psoriatic arthritis. Sequence (a) shows the precontrast image; sequences (b–d) show images acquired after 36, 90, and 180 s, respectively. The region of interest on which the enhancement curve has been calculate... |
PMC1175035_F3_2448.jpg | What is the principal component of this image? | Peripheral quantitative computed tomography (pQCT) scans of one representative mouse in each group. Trabecular bone mineral density (BMD) was determined with a metaphyseal scan at a point 3% of the length of the femur from the growth plate and the inner 45% of the area was defined as the trabecular bone compartment. (a... |
PMC1175035_F3_2449.jpg | What object or scene is depicted here? | Peripheral quantitative computed tomography (pQCT) scans of one representative mouse in each group. Trabecular bone mineral density (BMD) was determined with a metaphyseal scan at a point 3% of the length of the femur from the growth plate and the inner 45% of the area was defined as the trabecular bone compartment. (a... |
PMC1175035_F3_2451.jpg | What can you see in this picture? | Peripheral quantitative computed tomography (pQCT) scans of one representative mouse in each group. Trabecular bone mineral density (BMD) was determined with a metaphyseal scan at a point 3% of the length of the femur from the growth plate and the inner 45% of the area was defined as the trabecular bone compartment. (a... |
PMC1175035_F3_2450.jpg | What can you see in this picture? | Peripheral quantitative computed tomography (pQCT) scans of one representative mouse in each group. Trabecular bone mineral density (BMD) was determined with a metaphyseal scan at a point 3% of the length of the femur from the growth plate and the inner 45% of the area was defined as the trabecular bone compartment. (a... |
PMC1175055_F3_2453.jpg | What key item or scene is captured in this photo? | Immunohistochemical analysis of SDF1 and its receptor. Imunohistochemical staining of (a,b) SDF-1 and (c,d) the SDF-1 receptor CXCR4 in mammary tissues. The left panels show normal tissues, and the right panels show breast tumour tissues. CXCR, CXC chemokine receptor; SDF, stromal cell-derived factor. |
PMC1175055_F3_2452.jpg | What does this image primarily show? | Immunohistochemical analysis of SDF1 and its receptor. Imunohistochemical staining of (a,b) SDF-1 and (c,d) the SDF-1 receptor CXCR4 in mammary tissues. The left panels show normal tissues, and the right panels show breast tumour tissues. CXCR, CXC chemokine receptor; SDF, stromal cell-derived factor. |
PMC1175055_F3_2455.jpg | What key item or scene is captured in this photo? | Immunohistochemical analysis of SDF1 and its receptor. Imunohistochemical staining of (a,b) SDF-1 and (c,d) the SDF-1 receptor CXCR4 in mammary tissues. The left panels show normal tissues, and the right panels show breast tumour tissues. CXCR, CXC chemokine receptor; SDF, stromal cell-derived factor. |
PMC1175055_F3_2454.jpg | What object or scene is depicted here? | Immunohistochemical analysis of SDF1 and its receptor. Imunohistochemical staining of (a,b) SDF-1 and (c,d) the SDF-1 receptor CXCR4 in mammary tissues. The left panels show normal tissues, and the right panels show breast tumour tissues. CXCR, CXC chemokine receptor; SDF, stromal cell-derived factor. |
PMC1175070_F1_2464.jpg | What is the core subject represented in this visual? | Tumor cell diapedesis through human microvascular endothelial cell (HMVEC) monolayers. HBL100 cells were pre-labeled with dioctadecyl-3, 3,3', 3'-tetramethylindocarbocyanine percholate (DiI; red), co-cultured with HMVEC monolayers for various time periods, fixed with paraformaldehyde and labeled for F-actin (green). Op... |
PMC1175070_F1_2462.jpg | What stands out most in this visual? | Tumor cell diapedesis through human microvascular endothelial cell (HMVEC) monolayers. HBL100 cells were pre-labeled with dioctadecyl-3, 3,3', 3'-tetramethylindocarbocyanine percholate (DiI; red), co-cultured with HMVEC monolayers for various time periods, fixed with paraformaldehyde and labeled for F-actin (green). Op... |
PMC1175070_F1_2468.jpg | What can you see in this picture? | Tumor cell diapedesis through human microvascular endothelial cell (HMVEC) monolayers. HBL100 cells were pre-labeled with dioctadecyl-3, 3,3', 3'-tetramethylindocarbocyanine percholate (DiI; red), co-cultured with HMVEC monolayers for various time periods, fixed with paraformaldehyde and labeled for F-actin (green). Op... |
PMC1175070_F1_2457.jpg | Describe the main subject of this image. | Tumor cell diapedesis through human microvascular endothelial cell (HMVEC) monolayers. HBL100 cells were pre-labeled with dioctadecyl-3, 3,3', 3'-tetramethylindocarbocyanine percholate (DiI; red), co-cultured with HMVEC monolayers for various time periods, fixed with paraformaldehyde and labeled for F-actin (green). Op... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.